Osana Vilma Rondón García¹, Alicia Tamayo Figueroa²*, Eddy Sánchez Noda³, Ragnar Calzado Calderón⁴ and Lic Juan Carlos Álvarez Rodríguez⁵

¹2^nd Degree Specialist in Radiology, Havana, Cuba
²2^nd Degree Specialist in Orthopedics and Traumatology, Instructor Professor, Havana, Cuba
³2^nd Degree Specialist in Pathology, Auxiliar Professor, Havana, Cuba
⁴2^nd Degree Specialist in Orthopedics and Traumatology, Assistant Professor, Havana, Cuba
⁵Defectology and Physiotherapist, Assistant Professor, Havana, Cuba

*Corresponding Author: Alicia Tamayo Figueroa, 2^nd Degree Specialist in Orthopedics and Traumatology, Instructor Professor, Havana, Cuba.

Received: February 22, 2022; Published: April 12, 2022

Abstract

We present a 28-year-old male patient with a history of health who 4 months before going to the center began to present pain in the upper dorsal spine that radiated to the right scapula after physical exertion, improving little with the usual treatments, which is why he went to the doctor, who indicated X-rays, presenting multiples sclerotic lesions in pelvis, both humerus and proximal femurs. Given the diagnostic possibility of systemic bone mastocytosis, decides to admit it for study. Because it is an infrequent and difficult to treat tumor, it is an important to take advantage of the scientific-technical means that we have at our disposal that help us reach a diagnosis of certainty.

Keywords: Mastocytosis; Hematology; Diagnosis

References

1. Muro MD., et al. “Mastocytosis and clinical expression. A follow-up study of three cases”. Spain Allergology and Clinic Immunology Journal 9 (1994): 277-281.
2. Horny HP., et al. “Mastocytosis (Mast cell disease)”. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, eds. World Health Organization (WHO). Classification of Tumours. Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues, IARC Press: Lyon, France 2 (2008): 54-63.
3. Lim KH., et al. “Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors”. Blood 113 (2009): 5727-5736.
4. Sánchez Montero MB., et al. “Bone Mastocytosis, diagnosis”. Internal Medicine 17 (2000): 267-273.
5. Uzcátegui L and Rodríguez Santana. “Bone metabolism unusual diseases in adolescents”. Sclerosis disease. In REEMO, 8 (1999): 74-79.
6. “Bone disease radiologic diagnosis: Panam Ed”. Mexico (1984): 325-334.
7. “Non frecuent osteoporosis causes”. II Virtual Patology Hispanoamerican Congress (1998).
8. Schoanaers P., et al. “Systemic mastocytosis, an unusual cause of osteoporosis”. Clinical Rheumatology 6 (1987): 458-462.
9. Grardel B and Hardouin P. “Mastocytosis and bone manifestations. Results of the survey of the bone and phosphorus-calcium metabolism. Section of the French Society of Rheumatology”. Revue du rhumatisme et des maladies ostéo-articulaires 9 (1992): 57-63.
10. Horny HP., et al. “WHO Classification of tumors of hematopoietic and lymphoid tissues”. Lyon: IARC, (2008): 54-63.
11. Metcalfe DD. “Mast cells and mastocytosis”. Blood 112 (2008): 946-956.
12. Caplan RM. “The natural course of urticaria pigmentosa. Analysis and follow up of 112 cases”. Archives of Dermatology 87 (1963): 146-157.
13. Uzzaman A., et al. “Pediatric-onset mastocytosis: a long term clinical follow up and correlation with bone marrow histopathology”. Pediatrics Blood Cancer 53 (2009): 629-634.
14. Lim KH., et al. “Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors”. Blood 113 (2009): 5727-5736.
15. Donald Resnick MD. “Bone and articulations in Image 2da Ed”. Marban books, SL (1998): 640-648.
16. Moura DS., et al. “Evidence for cognitive impairment in mastocytosis: prevalence, featuresand correlations to depression”. PloS One 7 (2012): 39468.
17. Moura DS., et al. “Depression in patients with mastocytosis: prevalence, features and effects of mast therapy”. PloS One 6 (2011): 26375.
18. Johnstone PA., et al. “Radiotherapy of refractary bone pain due to systemic mast cell disease”. American Journal of Clinical Oncology 17 (1995): 328-330.
19. Horan RF., et al. “Cromolyn sodium in the management of systemic mastocytosis”. JACI 85 (1990): 852-855.
20. Lim AY., et al. “Systemic mastocytosis: a rare cause of osteoporosis and its response to biphosphonate treatment”. Annals of the Rheumatic Diseases 64 (2005): 965-966.
21. Valent P., et al. “Diagnostic criteria and classification of mastocytosis: a consensus proposal”. Leukemia Research 25 (2001): 603-625.
22. Alvarez-Twose I., et al. “Complete response after imatinib mesylate therapy in a patient with well-differentiated systemic mastocytosis”. Journal of Clinical Oncology 30 (2012): 126-129.

Citation

Citation: Alicia Tamayo Figueroa., et al. “Bone Presentation of a Systemic Mastocytosis: Clinical, Imaging and Histopathology".Acta Scientific Orthopaedics 5.5 (2022): 53-58.

Copyright

Copyright: © 2022 Alicia Tamayo Figueroa., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.